A carregar...
Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
Orphan drugs are often approved under exceptional circumstances, requiring submission of additional data on safety and effectiveness through registries. These registries are mainly focused on one drug only and data is frequently incomplete. Some registries also address phenotypic heterogeneity and n...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3102605/ https://ncbi.nlm.nih.gov/pubmed/21496291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-6-16 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|